Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Feb 27, 2024 11:27am
139 Views
Post# 35901469

RE:RE:RE:RE:RE:Very strange , even for ONC

RE:RE:RE:RE:RE:Very strange , even for ONC

Absolutely anything is possible, even they hay have nothing going on.
What I do know 100% factual; they are over a week late for year end " notice".
As was published previously,last year was N.R. On the 21 st & Q4 on March 3rd.
looking historically, those dates don't vary by more than a few days.
Could be they will quietly do the Q4 / yr end update with little promotion?
Could be there is a lot going on with inherent variables?
assuming no buyout-partership or other surprise, thet are legally bound to bring forward various reportings.
Could a takeover negotiation circumvent a Q4 report?
Yes, if announced before. THEN the Q4 numbers would become part of the overall package to be voted on.
Or.
Could be absolutely nothing & just delays. 
I know companies must submit reports publicly, I'm not sure if they need to give advance notice.
either way, they are a week late.
Never happened in the 20+ years.
 

<< Previous
Bullboard Posts
Next >>